8-K
filed August 3, 2023, 7:59 PM ET
ticker RMD
CIK 0000943819
earnings
confidence high
sentiment positive
materiality 0.75
ResMed Q4 FY2023 revenue up 23% to $1.12B; EPS $1.56 GAAP, dividend raised 9% to $0.48
RESMED INC
2023-FY EPS reported
$6.09
revenue$4,222,993,000
- Revenue $1,122.1M +23% YoY; GAAP diluted EPS $1.56 (+17%), non-GAAP $1.60 (+7%).
- Full-year revenue $4,223.0M (+18%); GAAP EPS $6.09 (+15%), non-GAAP $6.44 (+11%).
- Gross margin contracted 210 bps to 55.0% (GAAP) and 200 bps to 55.8% (non-GAAP).
- Quarterly dividend raised 9% to $0.48/share; record Aug 17, payable Sept 21, 2023.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
RESMED INC reported fiscal year ended June 30, 2023 results: revenue $4,223.0, net income $897.6, EPS $6.09.
- Period
- fiscal year ended June 30, 2023
- Revenue
- $4,223.0
- Net income
- $897.6
- EPS
- $6.09
- Result
- reported results
Exact text from the filing
per share $ 1.56 $ 1.33 17 Non-GAAP diluted earnings per share (B) $ 1.60 $ 1.49 7 Twelve Months Ended June 30, 2023 June 30, 2022 % Change Constant Currency (A) Revenue $ 4,223.0 $ 3,578.1 18 % 21 % Gross margin 55.8 % 56.6 % (1 ) Non-GAAP gross margin (B) 56.5 % 57.7 % (2 ) Selling, general, and administrative expenses 874.0 737.5 19 22 Research and
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
RESMED INC reported the quarter ended June 30, 2023 results: revenue $1,122.1, net income $229.7, EPS $1.56.
- Period
- the quarter ended June 30, 2023
- Revenue
- $1,122.1
- Net income
- $229.7
- EPS
- $1.56
- Result
- reported results
Exact text from the filing
Results and Operating Metrics Unaudited; $ in millions, except for per share amounts Three Months Ended June 30, 2023 June 30, 2022 % Change Constant Currency (A) Revenue $ 1,122.1 $ 914.7 23 % 23 % Gross margin 55.0 % 57.1 % (4 ) Non-GAAP gross margin (B) 55.8 % 57.8 % (4 ) Selling, general, and administrative expenses 240.7 193.0 25 26 Research and
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.